Literature DB >> 26460764

Experts critical of America's right-to-try drug laws.

Rita Rubin.   

Abstract

Mesh：

Year:  2015        PMID： 26460764     DOI： 10.1016/S0140-6736(15)00393-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  The changing landscape of expanded access to investigational drugs for patients with unmet medical needs: ethical implications.

Authors:  Eline M Bunnik; Nikkie Aarts; Suzanne van de Vathorst
Journal:  J Pharm Policy Pract       Date:  2017-02-21

2.  The 'false hope' argument in discussions on expanded access to investigational drugs: a critical assessment.

Authors:  Marjolijn Hordijk; Stefan F Vermeulen; Eline M Bunnik
Journal:  Med Health Care Philos       Date:  2022-08-11

3.  "I Think It's Been Met With a Shrug:" Oncologists' Views Toward and Experiences With Right-to-Try.

Authors:  Cambray Smith; Jeremiah Stout; Alex A Adjei; Jan Buckner; Mark Wentworth; Jon Tilburt; Zubin Master
Journal:  J Natl Cancer Inst       Date:  2021-06-01       Impact factor: 13.506
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.